Sponsored Content by Bristol Myers Squibb
Melanoma is one of the most common forms of cancer in the United States, and the incidence of the disease has increased over the past 25 years. The disease will spread or become advanced in approximately four percent of patients. Historically, median survival for these patients was measured in months.
Increasingly, people affected by advanced melanoma may have reasons to feel optimistic about available treatments, including immunotherapy, which works with the body’s own immune system to help fight cancer. Recent information about one such immunotherapy combination that treats certain patients with this disease underscores its potential in treating advanced melanoma, which has spread or cannot be removed by surgery.
The above video and article is paid commercial program. The opinions and views expressed belong to its sponsors and are not those of Nexstar Broadcasting, Inc., this station or their affiliates or employees.